Big Gain For Sophiris Bio, Inc.
Fri, Mar 13, 2020 at 05:30 PM
Sophiris Bio, Inc. (SPHS:NASDAQ) rocketted at $0.18, a gain of 80%. On Thu 12 Mar 20, SPHS:NASDAQ hit a New 2-Week Low of $0.1. The stock appeared on our News Catalysts scanner on Wed 11 Mar 20 at 08:47 AM in the 'INVESTOR UPDATE' category. From Thu 27 Feb 20, the stock recorded 30.00% Up Days and 27.27% Green Days
About Sophiris Bio, Inc. (SPHS:NASDAQ)
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.
Top 10 Gainers:
- Gulfport Energy Corporation (GPOR:NASDAQ), 585%
- Oasis Petroleum Inc. (OAS:NYSE), 169.69%
- Oasis Petroleum Inc. (OAS:NASDAQ), 169.69%
- Diamond Offshore Drilling, Inc. (DO:NYSE), 164.79%
- PDC Energy, Inc. (PDCE:NASDAQ), 149.65%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 109.92%
- Chesapeake Energy Corporation (CHK:NYSE), 95.95%
- Summit Midstream Partners, LP (SMLP:NYSE), 91.43%
- Forum Energy Technologies, Inc. (FET:NYSE), 82.98%
- Sophiris Bio, Inc. (SPHS:NASDAQ), 80%